Training Non-Oncologist Healthcare Providers to Manage Oral Endocrine Therapy for Breast Cancer The immune system of living being has evolved via the action of immune defense mechanism by utilizing ...

The innate immune system serves as the body's first line of defence, rapidly detecting and responding to external pathogens and internal damage. Recent advances in the field have highlighted the ...

Innate immune sensors—known as pattern recognition receptors (PRRs)—detect specific molecular components of bacterial or ...

Researchers have deciphered the complex interplay of various enzymes around the innate immune receptor toll-like receptor 7 (TLR7), which plays an important role in defending our bodies against ...

Scavenger receptors (SRs) comprise a heterogeneous family of proteins that play a pivotal role in the innate immune response. By recognising and binding a diverse array of ligands—from modified ...

When a transplanted organ arrives, it’s like a controlled burn that risks becoming a wildfire. The body’s innate immune system senses damage signals, like heat shock proteins (HSP70), and sounds the ...

Kupando raised an additional €10 million in Series A financing, bringing the total Series A funding to €23 million.Investment again led by Remiges Ventures, co-led by LifeCare Partners, with ...

Immunologists have identified an important intermediate step in innate immune defense. If bacteria enter the body, it often takes just a few minutes for the innate immune system to recognise them as ...

The farnesoid X receptor (FXR), a bile acid receptor, plays a direct role regulating innate immune cells in the gut, and treating mice with an FXR agonist improved symptoms of inflammatory bowel ...

Kupando has raised an additional €10M in Series A financing, bringing its total to €23M, to fund Phase 1b trials of KUP101.

T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on ...

Pheast Therapeutics, a clinical-stage biotechnology company advancing macrophage-directed immunotherapies for cancer, today announced that it will present three abstracts at the American Association ...